The emerging therapy of the medication represents a exciting breakthrough in the care of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide092546.laowaiblog.com/40672106/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment